INFLAMMOPHARMACOLOGY

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas: Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress statesRheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugsGastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agentsNeuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and painNovel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDsMuscle-immune interactions during inflammation: mechanisms of inflammation and anti-inflammatory actions of therapeutic agents on skeletal muscle under conditions of aging or injury.Safety and efficacy of Non-prescription (OTC) and prescription NSAIDs and Analgesics

炎症药理学是国际基础与临床药理学联合会(IUPHAR)和匈牙利实验与临床药理学学会(HECPS)胃肠部的官方出版物。炎症药理学发表关于炎症及其药理学控制的所有方面的论文，强调比较(a)不同的炎症状态，(b)用于炎症条件治疗的药物的作用、治疗效果和安全性。炎症条件类型的比较方面包括胃肠道疾病(如溃疡性结肠炎、克罗恩病)、寄生虫病、药物和环境制剂作用的毒理学表现、关节炎条件以及损伤或老化对骨骼肌的炎症影响。该杂志有七个主要的兴趣领域:药物-疾病的相互作用-条件药理学-也就是说，条件(疾病或压力状态)影响治疗反应和抗炎药物的副作用。药物-疾病的机制和药物-疾病的相互作用以及不同应激状态的作用风湿病学-特别强调测量新制剂的临床反应效果的方法，抗风湿药物的副作用胃肠病学-特别强调动物和人类的模型，粘膜炎症和溃疡的机制和新的和建立的抗溃疡，消炎剂，或抗寄生虫剂的效果神经炎症与疼痛模型系统，新型镇痛药的药理学和神经炎症与疼痛的机制新型药物、天然产品和营养保健品——以及它们对炎症过程的影响，特别是与传统药物(如非甾体抗炎药)相比，有新模式作用的迹象的地方炎症过程中的肌肉免疫相互作用:炎症机制和治疗药物在衰老或损伤条件下对骨骼肌的抗炎作用。非处方药(OTC)和非处方药、镇痛药的安全性和有效性